Multi-Omics Integration: Data Integration Techniques

Introduction

Multi-omics integration combines genomics, transcriptomics, proteomics, and metabolomics data to uncover comprehensive biological insights beyond single-omics analysis. This guide explains accessible methods, tools, and workflows for researchers integrating heterogeneous datasets to reveal disease mechanisms, biomarkers, and personalized medicine signatures.

What is Multi-Omics Integration?

Modern biology generates diverse data types:

  • Genomics: DNA mutations, CNVs
  • Transcriptomics: RNA-seq expression
  • Proteomics: Protein abundance
  • Metabolomics: Metabolite levels

Challenges:

  • High dimensionality (10k-1M features)
  • Missing values and batch effects
  • Heterogeneous scales and data types
  • Sample overlap issues

Goals: Find shared patterns across omics revealing cellular states or disease subtypes.

Early vs Late Integration Strategies

Early Integration (Concatenation)

  • Combine all features → Single matrix → Analysis (PCA, clustering)
  • Pros: Simple
  • Cons: Feature imbalance dominates

Late Integration (Separate Analysis)

  • Analyze each omic → Integrate results (e.g., pathway scores)
  • Pros: Handles heterogeneity
  • Cons: Misses cross-omic interactions

Intermediate (Recommended): Joint embedding methods

Key Integration Methods Explained

MOFA (Multi-Omics Factor Analysis)

Unsupervised factor analysis generalizing PCA to multiple data types.

Python Example (Muon/Scanpy):


    import muon as mu 
    mdata = mu.read("multiomics.h5mu")  # Genomics + Transcriptomics 
    mu.tl.mofa(mdata, n_factors=10, gpu_mode=True) 
    mdata.obsm["X_mofa"]  # Joint latent space
                  

Strengths: Interpretable factors, handles missing data, view-specific weights.

iCluster (Integrative Clustering)

Joint clustering via latent variables for classification tasks.

R Example:


    library(iClusterPlus)
    # X1: genomics, X2: transcriptomics, X3: proteomics 
    res <- iClusterPlus(cbind(X1, X2, X3), n.cluster=3) 
    plot(res)  # Subtype discovery
                  

NEMO (Neighbor-Edge Multi-Omics)

Graph-based kernel integration for non-linear relationships.

Deep Learning Approaches (VAEs)

Variational Autoencoder for joint embedding:


    from sklearn.preprocessing import StandardScaler 
    #  Scale each omic → Concatenate → VAE encoder → Latent space
                  

Method Comparison Matrix

Method Type Strengths Limitations Best For
MOFA Factor Analysis Interpretable, missing data OK GitHub Linear assumptions Unsupervised exploration
iCluster Bayesian Clustering Subtype discovery bioconductor Requires balanced omics Cancer classification
NEMO Similarity Kernel Non-linear patterns Computationally intensive Complex interactions
VAE/DL Deep Generative Batch correction, imputation arvix Black-box, data hungry Large datasets
intNMF Matrix Factorization Feature selection UPM Scalability limits Biomarker discovery

Workflow Implementation Steps

1. Data Preparation:

  • Normalize each omic (logCPM, z-score)
  • Handle missing values (imputation)
  • Batch correction (Combat)

2. Integration:

  • MOFA/iCluster → Latent factors/clusters
  • Downstream: DE analysis, pathway enrichment

3. Validation:

  • Cross-validation, silhouette scores
  • Biological interpretability

Practical Code Workflow (Snakemake/Nextflow)

Snakemake Rule for MOFA:


    rule mofa_integration: 
        input: 
            rna="processed/rna.h5ad", 
            dna="processed/dna.h5ad" 
        output: "results/mofa_factors.h5ad" 
        script: "scripts/run_mofa.py"
                  

SyncBio Bioinformatics Applications

SyncBio Bioinformatics applies multi-omics integration in precision medicine pipelines:

Projects:

  • PersonalizedRx: MOFA on TCGA (genomics+transcriptomics)
  • PathoML-Omics: iCluster for cancer subtyping
  • CloudBioML: VAE foundation models

Implementation:

  • Development: Snakemake + MOFA Python
  • Production: Nextflow + GPU clusters
  • Results: 25% improved subtype accuracy

Key Outcomes:

  • Identified novel cancer subtypes
  • 40% biomarker discovery speedup
  • EU grant applications (quantitative bioinformatics)

This approach powers SyncBio's molecular diagnostics and supports international collaborations in personalized medicine.

Need Expert Guidance?

Our team can help you implement these strategies effectively.

Contact Us